NCT01529788View on ClinicalTrials.gov

Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2014

Conditions
Intrinsic Aging of SkinSolar Elastosis
Interventions
DRUG

Right lateral orbital injection of Botox Cosmetic or Dysport

Right lateral orbital injection of Botox Cosmetic or Dysport (10 units and 30 units, respectively) divided among 4 injection points (0.05 mL \[7.5 units\] per injection point) divided among 4 injection points (0.05mL \[2.5units\]) on Day 0 of the study

DRUG

Left lateral orbital injection of Botox Cosmetic or Dysport

Left lateral orbital injection of Botox Cosmetic or Dysport (10 units and 30 units, respectively) divided among 4 injection points (0.05 mL \[7.5 units\] per injection point) divided among 4 injection points (0.05mL \[2.5units\]) on Day 0 of the study

Trial Locations (1)

94115

The Maas Clinic, San Francisco

Sponsors
All Listed Sponsors
collaborator

Medicis Pharmaceutical Corporation

INDUSTRY

lead

The Maas Clinic

OTHER